SG-ARAs provide similar therapeutic benefit to abiraterone, a potent CYP17 inhibitor, and do not require the co-administration of prednisone
FIGURE 2 In addition to high mitochondrial ROS emission, vitiligo patients have a deficient EAS, with low activity and low gene expression of catalase (CAT), glutathione peroxidase (GPx), and thioredoxin reductase (TrxR) (Xie et al., 2016), leading to a chronic OS state (Schallreuter, 2014)
Targeted Support for Chemical Sensitivity and MTHFR For people with MTHFR variants or chemical sensitivity, targeted support can restore processing capacity more effectively
Who Is a Candidate for Peptide Therapy
Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ (2020) COVID-19: consider cytokine storm syndromes and immunosuppression